从功能到等离子蛋白质的因果作用:综合观察和门德尔随机化分析,英国生物库参与者>50,000人
Jeong Min Cho1,2, Minsang Kim3, Jaeik Oh1,3
1Department of Translational Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Proteomics. Clinical applications
|February 27, 2025
概括
降低功能因果影响383种血蛋白,381种增加,特别是与炎症和亡相关的蛋白质. 瘤亡因子 (TNF) 途径是慢性病进展的关键.
科学领域:
- 蛋白质基因组学是什么
- 系统生物学 系统生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 慢性病 (CKD) 显著增加患病率和死亡率,由于系统性影响,如炎症和亡.
- 功能下降和系统性蛋白质组变化之间的确切因果关系尚不清楚.
研究的目的:
- 为了研究估计的淋巴膜过率 (eGFR) 和血蛋白水平之间的因果关系.
- 为了确定受功能下降影响的特定血蛋白和途径.
主要方法:
- 综合门德尔随机化 (MR) 和观察分析.
- 利用英国生物库数据 (50,407名参与者) 和CKDGen第四阶段GWAS元分析.
- 分析了1815个血蛋白质概况.
主要成果:
- 鉴定出383种与EGFR因果相关的血蛋白.
- 降低功能增加了381种蛋白质水平 (例如TNF,IGFBP4) 和降低了2种 (NPHS1,SPOCK1).
- 亡途径得到了丰富;TNF成为炎症和纤维化途径中的枢纽蛋白.
结论:
- 383种血蛋白与EGFR有因果关系.
- 与TNF相关的途径在病进展,全身炎症和器官纤维化中至关重要.
- 对这些途径的进一步研究是有必要的.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
47
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
Kidney Structure
68.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.5K
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
159
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
159
Physiological Pharmacokinetic Models: Assumption with Protein Binding
29
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
29
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
34
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
34


